{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:06:43Z","timestamp":1790770003933,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,10,15]],"date-time":"2014-10-15T00:00:00Z","timestamp":1413331200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2407-14-764","type":"journal-article","created":{"date-parts":[[2014,10,15]],"date-time":"2014-10-15T07:01:23Z","timestamp":1413356483000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Racial differences in mantle cell lymphoma in the United States"],"prefix":"10.1186","volume":"14","author":[{"given":"Yu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangge","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,10,15]]},"reference":[{"key":"4945_CR1","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1517\/17530059.2011.618185","volume":"5","author":"Y Zhang","year":"2011","unstructured":"Zhang Y, Dai Y, Zheng T, Ma S: Risk factors of non-Hodgkin lymphoma. Expert Opin Med Diagn. 2011, 5: 539-550. 10.1517\/17530059.2011.618185.","journal-title":"Expert Opin Med Diagn"},{"key":"4945_CR2","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1097\/00000478-199207000-00001","volume":"16","author":"PM Banks","year":"1992","unstructured":"Banks PM, Chan J, Cleary ML, Delsol G, De Wolf-Peeters C, Gatter K, Grogan TM, Harris NL, Isaacson PG, Jaffe ES, Mason D, Pileri S, Ralfkiaer E, Stein H, Wanke RA: Mantle cell lymphoma. A proposal for unification of morphologic, immunologic, and molecular data. Am J Surg Pathol. 1992, 16: 637-640. 10.1097\/00000478-199207000-00001.","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"4945_CR3","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.5858\/1999-123-1182-MCL","volume":"123","author":"RC Hankin","year":"1999","unstructured":"Hankin RC, Hunter SV: Mantle cell lymphoma. Arch Pathol Lab Med. 1999, 123 (12): 1182-1188.","journal-title":"Arch Pathol Lab Med"},{"issue":"4","key":"4945_CR4","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1002\/cncr.23608","volume":"113","author":"Y Zhou","year":"2008","unstructured":"Zhou Y, Wang H, Fang W, Romaguer JE, Zhang Y, Delasalle KB, Kwak L, Yi Q, Du XL, Wang M: Incidence trends of mantle cell lymphoma in the United States between 1992 and 2004. Cancer. 2008, 113 (4): 791-798. 10.1002\/cncr.23608.","journal-title":"Cancer"},{"key":"4945_CR5","volume-title":"SEER Cancer Statistics Review 1975\u20132009","author":"N Howlader","year":"2012","unstructured":"Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Waldron W, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Chen HS, Feuer EJ, Cronin KA: SEER Cancer Statistics Review 1975\u20132009. 2012, Bethesda, MD: National Cancer Institute, Based on November 2010 SEER data submission"},{"key":"4945_CR6","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/nrc2230","volume":"7","author":"P Jares","year":"2007","unstructured":"Jares P, Colomer D, Campo E: Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics. Nat Rev Cancer. 2007, 7: 750-762. 10.1038\/nrc2230.","journal-title":"Nat Rev Cancer"},{"key":"4945_CR7","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1007\/s00277-012-1534-y","volume":"91","author":"M Witzens-Harig","year":"2012","unstructured":"Witzens-Harig M, Hess G, Atta J, Zaiss M, Lenz G, Scholz C, Repp R, Reiser M, Pott C, Pelz H, La Ros\u00e9e P, Kirchner H, Kiewe P, Keller U, Buske C, Viardot A, Dreyling M: Current treatment of mantle cell lymphoma: results of a national survey and consensus meeting. Ann Hematol. 2012, 91: 1765-1772. 10.1007\/s00277-012-1534-y.","journal-title":"Ann Hematol"},{"issue":"4","key":"4945_CR8","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1200\/JCO.2008.16.8435","volume":"27","author":"A Herrmann","year":"2009","unstructured":"Herrmann A, Hoster E, Zwingers T, Brittinger G, Engelhard M, Meusers P, Reiser M, Forstpointner R, Metzner B, Peter N, W\u00f6rmann B, Tr\u00fcmper L, Pfreundschuh M, Einsele H, Hiddemann W, Unterhalt M, Dreyling M: Improvement of overall survival in advanced stage mantle cell lymphoma. J Clin Oncol. 2009, 27 (4): 511-518.","journal-title":"J Clin Oncol"},{"issue":"3","key":"4945_CR9","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1053\/j.seminhematol.2011.06.001","volume":"48","author":"E Hoster","year":"2011","unstructured":"Hoster E: Prognostic relevance of clinical risk factors in mantle cell lymphoma. Semin Hematol. 2011, 48 (3): 185-188. 10.1053\/j.seminhematol.2011.06.001.","journal-title":"Semin Hematol"},{"issue":"8","key":"4945_CR10","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.3109\/10428194.2012.656628","volume":"53","author":"R Chandran","year":"2012","unstructured":"Chandran R, Gardiner SK, Simon M, Spurgeon SE: Survival trends in mantle cell lymphoma in the United States over 16\u00a0years 1992\u20132007. Leuk Lymphoma. 2012, 53 (8): 1488-1493. 10.3109\/10428194.2012.656628.","journal-title":"Leuk Lymphoma"},{"issue":"11","key":"4945_CR11","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1002\/cncr.25765","volume":"117","author":"PJ Shenoy","year":"2010","unstructured":"Shenoy PJ, Malik N, Nooka A, Sinha R, Ward KC, Brawley OW, Lipscomb J, Flowers CR: Racial differences in the presentation and outcomes of diffuse large B-cell lymphoma in the United States. Cancer. 2010, 117 (11): 2530-2540.","journal-title":"Cancer"},{"key":"4945_CR12","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1186\/1471-2407-10-625","volume":"10","author":"R Griffiths","year":"2010","unstructured":"Griffiths R, Gleeson M, Knopf K, Danese M: Racial differences in treatment and survival in older patients with diffuse large B-cell lymphoma (DLBCL). BMC Cancer. 2010, 10: 625-10.1186\/1471-2407-10-625.","journal-title":"BMC Cancer"},{"key":"4945_CR13","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3109\/10428194.2012.708751","volume":"54","author":"CR Flowers","year":"2013","unstructured":"Flowers CR, Shenoy PJ, Borate U, Bumpers K, Douglas-Holland T, King N, Brawley OW, Lipscomb J, Lechowicz MJ, Sinha R, Grover RS, Bernal-Mizrachi L, Kowalski J, Donnellan W, The A, Reddy V, Jaye DL, Foran J: Examining racial differences in diffuse large B-cell lymphoma presentation and survival. Leuk Lymphoma. 2013, 54: 268-276. 10.3109\/10428194.2012.708751.","journal-title":"Leuk Lymphoma"},{"key":"4945_CR14","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1093\/annonc\/mdr578","volume":"23","author":"AM Evens","year":"2012","unstructured":"Evens AM, Antill\u00f3n M, Aschebrook-Kilfoy B, Chiu BC: Racial disparities in Hodgkin\u2019s lymphoma: a comprehensive population-based analysis. Ann Oncol. 2012, 23: 2128-2137. 10.1093\/annonc\/mdr578.","journal-title":"Ann Oncol"},{"key":"4945_CR15","doi-asserted-by":"publisher","first-page":"4842","DOI":"10.1002\/cncr.27513","volume":"118","author":"C Nabhan","year":"2012","unstructured":"Nabhan C, Byrtek M, Taylor MD, Friedberg JW, Cerhan JR, Hainsworth JD, Miller TP, Hirata J, Link BK, Flowers CR: Racial differences in presentation and management of follicular non-Hodgkin lymphoma in the United States: report from the national LymphoCare study. Cancer. 2012, 118: 4842-4850. 10.1002\/cncr.27513.","journal-title":"Cancer"},{"key":"4945_CR16","first-page":"158","volume":"39","author":"I Kato","year":"2012","unstructured":"Kato I, Booza J, Quarshie WO, Schwartz K: Persistent socioeconomic inequalities in cancer survival in the United States: 1973\u20132007 surveillance, epidemiology and end results (SEER) data for breast cancer and non-Hodgkin\u2019s lymphoma. J Registry Manag. 2012, 39: 158-166.","journal-title":"J Registry Manag"},{"key":"4945_CR17","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1158\/1055-9965.EPI-12-0466","volume":"21","author":"CR Flowers","year":"2012","unstructured":"Flowers CR, Fedewa SA, Chen AY, Nastoupil LJ, Lipscomb J, Brawley OW, Ward EM: Disparities in the early adoption of chemoimmunotherapy for diffuse large B-cell lymphoma in the United States. Cancer Epidemiol Biomarkers Prev. 2012, 21: 1520-1530. 10.1158\/1055-9965.EPI-12-0466.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"4945_CR18","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.clml.2011.07.002","volume":"11","author":"PJ Shenoy","year":"2011","unstructured":"Shenoy PJ, Malik N, Sinha R, Nooka A, Nastoupil LJ, Smith M, Flowers CR: Racial differences in the presentation and outcomes of chronic lymphocytic leukemia and variants in the United States. Clin Lymphoma Myeloma Leuk. 2011, 11: 498-506. 10.1016\/j.clml.2011.07.002.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"4","key":"4945_CR19","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/(SICI)1096-8652(199812)59:4<295::AID-AJH5>3.0.CO;2-N","volume":"59","author":"CS Chim","year":"1998","unstructured":"Chim CS, Chan AC, Choo CK, Kwong YL, Lie AK, Liang R: Mantle cell lymphoma in the Chinese: clinicopathological features and treatment outcome. Am J Hematol. 1998, 59 (4): 295-301. 10.1002\/(SICI)1096-8652(199812)59:4<295::AID-AJH5>3.0.CO;2-N.","journal-title":"Am J Hematol"},{"key":"4945_CR20","doi-asserted-by":"publisher","first-page":"4808","DOI":"10.1182\/blood-2011-04-348367","volume":"118","author":"R Griffiths","year":"2011","unstructured":"Griffiths R, Mikhael J, Gleeson M, Danese M, Dreyling M: Addition of rituximab to chemotherapy alone as first-line therapy improves overall survival in elderly patients with mantle cell lymphoma. Blood. 2011, 118: 4808-4816. 10.1182\/blood-2011-04-348367.","journal-title":"Blood"},{"key":"4945_CR21","first-page":"101","volume":"6","author":"F Ederer","year":"1961","unstructured":"Ederer F, Axtell LM, Cutler SJ: The relative survival rate: a statistical methodology. NCI Monogr. 1961, 6: 101-121.","journal-title":"NCI Monogr"},{"key":"4945_CR22","doi-asserted-by":"crossref","unstructured":"Wang Y, Ma S: Risk factors for etiology and prognosis of mantle cell lymphoma. Expert Rev Hematol. In press","DOI":"10.1586\/17474086.2014.889561"},{"key":"4945_CR23","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1200\/JCO.2010.30.1515","volume":"29","author":"J Koshiol","year":"2011","unstructured":"Koshiol J, Lam TK, Gridley G, Check D, Brown LM, Landgren O: Racial differences in chronic immune stimulatory conditions and risk of non-Hodgkin\u2019s lymphoma in veterans from the United States. J Clin Oncol. 2011, 29: 378-385. 10.1200\/JCO.2010.30.1515.","journal-title":"J Clin Oncol"},{"key":"4945_CR24","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.semcancer.2011.09.010","volume":"21","author":"KE Smedby","year":"2011","unstructured":"Smedby KE, Hjalgrim H: Epidemiology and etiology of mantle cell lymphoma and other non-Hodgkin lymphoma subtypes. Semin Cancer Biol. 2011, 21: 293-298. 10.1016\/j.semcancer.2011.09.010.","journal-title":"Semin Cancer Biol"},{"key":"4945_CR25","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.ssresearch.2006.04.001","volume":"36","author":"JR Bulanda","year":"2007","unstructured":"Bulanda JR, Brown SL: Race-ethnic differences in marital quality and divorce. Soc Sci Res. 2007, 36: 945-967. 10.1016\/j.ssresearch.2006.04.001.","journal-title":"Soc Sci Res"},{"key":"4945_CR26","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.3109\/10428194.2012.760041","volume":"54","author":"B Aschebrook-Kilfoy","year":"2013","unstructured":"Aschebrook-Kilfoy B, Caces DB, Ollberding NJ, Smith SM, Chiu BC: An upward trend in the age-specific incidence patterns for mantle cell lymphoma in the USA. Leuk Lymphoma. 2013, 54: 1677-1683. 10.3109\/10428194.2012.760041.","journal-title":"Leuk Lymphoma"},{"key":"4945_CR27","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1017\/S0007114509992029","volume":"103","author":"E Erber","year":"2010","unstructured":"Erber E, Maskarinec G, Lim U, Kolonel LN: Dietary vitamin D and risk of non-Hodgkin lymphoma: the multiethnic cohort. Br J Nutr. 2010, 103: 581-584. 10.1017\/S0007114509992029.","journal-title":"Br J Nutr"},{"key":"4945_CR28","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1080\/10428190903030841","volume":"50","author":"E Erber","year":"2009","unstructured":"Erber E, Maskarinec G, Gill JK, Park SY, Kolonel LN: Dietary patterns and the risk of non-Hodgkin lymphoma: the multiethnic cohort. Leuk Lymphoma. 2009, 50: 1269-1275. 10.1080\/10428190903030841.","journal-title":"Leuk Lymphoma"},{"key":"4945_CR29","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1002\/ijc.23589","volume":"123","author":"M Eriksson","year":"2008","unstructured":"Eriksson M, Hardell L, Carlberg M, Akerman M: Pesticide exposure as risk factor for non-Hodgkin lymphoma including histopathological subgroup analysis. Int J Cancer. 2008, 123: 1657-1663. 10.1002\/ijc.23589.","journal-title":"Int J Cancer"},{"key":"4945_CR30","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1136\/oem.2009.046839","volume":"67","author":"P Cocco","year":"2010","unstructured":"Cocco P, t\u2019Mannetje A, Fadda D, Melis M, Becker N, de Sanjose S, Foretova L, Mareckova J, Staines A, Kleefeld S, Maynadi\u00e9 M, Nieters A, Brennan P, Boffetta P: Occupational exposure to solvents and risk of lymphoma subtypes: results from the Epilymph case\u2013control study. Occup Environ Med. 2010, 67: 341-347. 10.1136\/oem.2009.046839.","journal-title":"Occup Environ Med"},{"key":"4945_CR31","first-page":"189","volume":"4","author":"O Aminian","year":"2012","unstructured":"Aminian O, Abedi A, Chavoshi F, Ghasemi M, Najarkolaei FR: Evaluation of occupational risk factors in non-Hodgkin lymphoma and Hodgkin\u2019s disease in Iranian men. Iran J Cancer Prev. 2012, 4: 189-193.","journal-title":"Iran J Cancer Prev"},{"key":"4945_CR32","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1093\/aje\/kwp383","volume":"171","author":"CF Skibola","year":"2010","unstructured":"Skibola CF, Bracci PM, Nieters A, Brooks-Wilson A, de Sanjos\u00e9 S, Hughes AM, Cerhan JR, Skibola DR, Purdue M, Kane E, Lan Q, Foretova L, Schenk M, Spinelli JJ, Slager SL, De Roos AJ, Smith MT, Roman E, Cozen W, Boffetta P, Kricker A, Zheng T, Lightfoot T, Cocco P, Benavente Y, Zhang Y, Hartge P, Linet MS, Becker N, Brennan P: Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium. Am J Epidemiol. 2010, 171: 267-276. 10.1093\/aje\/kwp383.","journal-title":"Am J Epidemiol"},{"key":"4945_CR33","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0165-4608(98)00216-7","volume":"111","author":"KF Wong","year":"1999","unstructured":"Wong KF, Chan JK: Cytogenetic abnormalities in chronic B-cell lymphoproliferative disorders in Chinese patients. Cancer Genet Cytogenet. 1999, 111: 55-60. 10.1016\/S0165-4608(98)00216-7.","journal-title":"Cancer Genet Cytogenet"},{"issue":"9","key":"4945_CR34","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1093\/annonc\/mds023","volume":"23","author":"D Pulte","year":"2012","unstructured":"Pulte D, Redaniel MT, Brenner H, Jeffreys M: Changes in survival by ethnicity of patients with cancer between 1992\u20131996 and 2002\u20132006: is the discrepancy decreasing?. Ann Oncol. 2012, 23 (9): 2428-2434. 10.1093\/annonc\/mds023.","journal-title":"Ann Oncol"},{"issue":"8","key":"4945_CR35","doi-asserted-by":"publisher","first-page":"3407","DOI":"10.1182\/blood-2005-10-4079","volume":"107","author":"T Katzenberger","year":"2006","unstructured":"Katzenberger T, Petzoldt C, H\u00f6ller S, M\u00e4der U, Kalla J, Adam P, Ott MM, M\u00fcller-Hermelink HK, Rosenwald A, Ott G: The Ki67 proliferation index is a quantitative indicator of clinical risk in mantle cell lymphoma. Blood. 2006, 107 (8): 3407-10.1182\/blood-2005-10-4079.","journal-title":"Blood"},{"issue":"20","key":"4945_CR36","doi-asserted-by":"publisher","first-page":"5307","DOI":"10.1158\/0008-5472.CAN-12-1615","volume":"72","author":"A Navarro","year":"2012","unstructured":"Navarro A, Clot G, Royo C, Jares P, Hadzidimitriou A, Agathangelidis A, Bikos V, Darzentas N, Papadaki T, Salaverria I, Pinyol M, Puig X, Palomero J, Vegliante MC, Amador V, Martinez-Trillos A, Stefancikova L, Wiestner A, Wilson W, Pott C, Calasanz MJ, Trim N, Erber W, Sander B, Ott G, Rosenwald A, Colomer D, Gin\u00e9 E, Siebert R, Lopez-Guillermo A: Status and SOX11 expression have distinct biologic and clinical features. Cancer Res. 2012, 72 (20): 5307-5316. 10.1158\/0008-5472.CAN-12-1615.","journal-title":"Cancer Res"},{"key":"4945_CR37","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S1535-6108(03)00028-X","volume":"3","author":"A Rosenwald","year":"2003","unstructured":"Rosenwald A, Wright G, Wiestner A, Chan WC, Connors JM, Campo E, Gascoyne RD, Grogan TM, Muller-Hermelink HK, Smeland EB, Chiorazzi M, Giltnane JM, Hurt EM, Zhao H, Averett L, Henrickson S, Yang L, Powell J, Wilson WH, Jaffe ES, Simon R, Klausner RD, Montserrat E, Bosch F, Greiner TC, Weisenburger DD, Sanger WG, Dave BJ, Lynch JC, Vose J: The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. Cancer Cell. 2003, 3: 185-197. 10.1016\/S1535-6108(03)00028-X.","journal-title":"Cancer Cell"},{"key":"4945_CR38","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1158\/1055-9965.EPI-05-0549","volume":"15","author":"CA Clarke","year":"2006","unstructured":"Clarke CA, Undurraga DM, Harasty PJ, Glaser SL, Morton LM, Holly EA: Changes in cancer registry coding for lymphoma subtypes: reliability over time and relevance for surveillance and study. Cancer Epidemiol Biomarkers Prev. 2006, 15: 630-638. 10.1158\/1055-9965.EPI-05-0549.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"8","key":"4945_CR39","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1007\/s00277-014-2049-5","volume":"93","author":"C Leux","year":"2014","unstructured":"Leux C, Maynadi\u00e9 M, Troussard X, Cabrera Q, Herry A, Le Guyader-Peyrou S, Le Gouill S, Monnereau A: Mantle cell lymphoma epidemiology: a population-based study in France. Ann Hematol. 2014, 93 (8): 1327-1333. 10.1007\/s00277-014-2049-5.","journal-title":"Ann Hematol"},{"issue":"Suppl 1","key":"4945_CR40","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1093\/annonc\/11.suppl_1.S63","volume":"11","author":"KN Naresh","year":"2000","unstructured":"Naresh KN, Srinivas V, Soman CS: Distribution of various subtypes of non-Hodgkin\u2019s lymphoma in India: a study of 2773 lymphomas using R.E.A.L. and WHO Classifications. Ann Oncol. 2000, 11 (Suppl 1): 63-67. 10.1093\/annonc\/11.suppl_1.S63.","journal-title":"Ann Oncol"},{"issue":"8","key":"4945_CR41","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1093\/annonc\/mdt139","volume":"24","author":"CY Cheah","year":"2013","unstructured":"Cheah CY, George A, Gine E, Gin\u00e9 E, Chiappella A, Kluin-Nelemans HC, Jurczak W, Krawczyk K, Mocikova H, Klener P, Salek D, Walewski J, Szymczyk M, Smolej L, Auer RL, Ritchie DS, Arcaini L, Williams ME, Dreyling M, Seymour JF, European Mantle Cell Lymphoma Network: Central nervous system involvement in mantle cell lymphoma: clinical features, prognostic factors and outcomes from the European Mantle Cell Lymphoma Network. Ann Oncol. 2013, 24 (8): 2119-2123. 10.1093\/annonc\/mdt139.","journal-title":"Ann Oncol"},{"issue":"3","key":"4945_CR42","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1093\/ije\/dyn064","volume":"37","author":"S Greenland","year":"2008","unstructured":"Greenland S: Multiple comparisons and association selection in general epidemiology. Int J Epidemiol. 2008, 37 (3): 430-434. 10.1093\/ije\/dyn064.","journal-title":"Int J Epidemiol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-764.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-14-764\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-764","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T00:01:29Z","timestamp":1650412889000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-14-764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,15]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["4945"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-14-764","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,15]]},"article-number":"764"}}